Please login to the form below

Not currently logged in
Email:
Password:

Alexion Pharmaceuticals

This page shows the latest Alexion Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

BMS pledges $300m to tackle health inequity and improve diversity

BMS pledges $300m to tackle health inequity and improve diversity

Earlier this month, Alexion Pharmaceuticals appointed its first chief diversity officer, with Uzair Qadeer taking on the role after serving as head of enterprise partnerships at the company.

Latest news

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Deal Watch table for January 2014 Deal Watch table for January 2014

    144. Moderna Therapeutics/ Alexion Pharmaceuticals. Exclusive discovery and development. Messenger RNA (mRNA) therapeutics in rare diseases for 10 product options. ... 100. Cancer Prevention Pharmaceuticals/ Zeria Tillotts Pharma. Exclusive licensing

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals

    Prior to CRISPR, he worked as head of translational medicine at Alexion Pharmaceuticals, and also served as chief medical officer of Taligen Therapeutics. ... Cagnoni, chief executive officer of Rubius. Titan Pharmaceuticals. Kate DeVarney has joined

  • Amryt Pharma appoints Jordi Casals as head of Europe Amryt Pharma appoints Jordi Casals as head of Europe

    He joins the company from Aegerion Pharmaceuticals. Amryt Pharma, a company focused on treatments for rare and orphan diseases, has appointed Jordi Casals as the biopharma’s head of Europe. ... Prior to this, he worked for eight years at Alexion

  • Alexion Pharmaceuticals adds to its board Alexion Pharmaceuticals adds to its board

    Judith Reinsdorf recently worked at Johnson Controls. Alexion Pharmaceuticals has appointed Judith Reinsdorf to its board of directors following her role as executive vice president and general counsel of Johnson Controls. ... David Brennan, chairman of

  • Belgium's TiGenix appoints Dr Gregory Gordon Belgium's TiGenix appoints Dr Gregory Gordon

    Dr Gordon joins TiGenix from Nestlé Health Science, where he was global clinical affairs lead, gastrointestinal health and prior to that he has worked at Stealth BioTherapeutics, Ironwood Pharmaceuticals and Parexel. ... Meanwhile, Valles-Sukkar arrives

  • Minoryx Therapeutics adds to board of directors Minoryx Therapeutics adds to board of directors

    Dr Nicaise founded Clinical Regulatory Services, a biotech-focused advisory service, in 2014, having previously served as senior vice president of strategic development and global regulatory affairs at Alexion Pharmaceuticals from

More from appointments
Approximately 1 fully matching, plus 8 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics